What is Quantum Biosystems?
Quantum Biosystems operates within the advanced scientific research and development sector. While the provided description pertains to a website comparing hair growth products, the company's name and substantial funding suggest a focus on cutting-edge biotechnology or life sciences. The enterprise-level capital raised points towards a company engaged in developing complex solutions, potentially in areas like genetic engineering, advanced diagnostics, or novel therapeutic development. The strategic investment indicates confidence from major players in its long-term vision and technological capabilities.
How much funding has Quantum Biosystems raised?
Quantum Biosystems has raised a total of $24.6M across 2 funding rounds:
Series A
$4.1M
Series B
$20.5M
Series A (2014): $4.1M with participation from Mizuho Capital Co., JAFCO, and UTEC
Series B (2015): $20.5M led by UTEC, Mitsubishi Corporation, Mizuho Capital, and JAFCO
Key Investors in Quantum Biosystems
UTEC
UTEC is a venture capital firm associated with the University of Tokyo, specializing in early-stage startups with exceptional intellectual property and talent. They focus on addressing global challenges through transformative science and technology.
Mitsubishi Corporation
Mitsubishi Corporation is a global integrated business enterprise involved in a wide array of industries, including industrial finance, energy, metals, and machinery, with a broad scope of business operations.
Mizuho Capital
Mizuho Capital is an investment firm that provides venture capital financing, likely focusing on technology and growth-stage companies within Japan and potentially internationally.
What's next for Quantum Biosystems?
The substantial enterprise-level funding and recent strategic investment position Quantum Biosystems for accelerated growth and market expansion. This capital infusion is likely to fuel further research and development, scale operational capacity, and potentially pursue strategic acquisitions or partnerships. The company's ability to attract significant backing from established entities like UTEC, Mitsubishi Corporation, Mizuho Capital, and JAFCO suggests a strong technological foundation and a clear path to commercialization. Future endeavors will likely focus on translating its scientific innovations into tangible products or services, solidifying its competitive advantage in the biotechnology landscape.
See full Quantum Biosystems company page
